Becomes the only clinical logistics provider with fully integrated services RESEARCH TRIANGLE PARK, N.C., Aug. 20, 2019 /PRNewswire/ — Marken announced today that its nursing services for home-based clinical trials are now operational in most key markets around...
Trial will evaluate the effectiveness of perivascular sirolimus to improve AV Fistula outcomes in patients with kidney disease Vascular Therapies, a biotechnology company focused on improving vascular access outcomes in patients with kidney disease, today announced...
– Rapid Dose Therapeutics Corp. (CSE: DOSE), (“RDT”) announced today the commencement of a clinical research trial with the GI Research Institute (“GIRI”) and the University of British Columbia (“UBC”) under the direction of...
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has completed enrollment in the company’s open-label, 24 patient, Phase 2 trial with its lead immunotherapy product VGX-3100 in patients with precancerous lesions of the anus, i.e. anal...
The US Centers for Disease Control and Prevention (CDC) estimates that the rate of sexually transmitted infections (STI) are on the rise with an estimated 1.7 million cases documented in 2017 in the United States. Although chlamydia can typically be successfully...
Immunic announced the first patient enrolled in a proof-of-concept clinical trial of IMU-838 for the treatment of primary sclerosing cholangitis, according to a press release. The National Institutes of Health awarded a grant to Keith Lindor, MD, principal...
Email
Text